Work

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.2307.2307

Authors: L. Norasetthada, M. B. Maris, B. M. Sandmaier, T. Gooley, S. Forman, E. Agura, R. T. Maziarz, J. Shizuru, D. Niederwieser, R. Storb, D. G. Maloney

Institutions: University of Washington, Fred Hutch Cancer Center, City Of Hope National Medical Center, City of Hope, Baylor University, Oregon Health & Science University, Stanford University, Leipzig University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2992359364

FWCI: 0.424

Cites:

Cited by: 4

Related to: 10